Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder
Completed · Phase 2
Conditions studied: Somatization Disorder
In brief
This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.
Key facts
- Study ID
- NCT00149760
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 88
- Starts
- 2003-08-01
- Expected to finish
- 2010-02-01
- Last updated by the study team
- 2014-02-20
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Meets DSM-IV criteria for somatization disorder
- Available for follow-up over the ensuing 18 months
- English-speaking
You may not qualify if…
- Meets DSM-IV criteria for a psychotic disorder, organic brain syndrome, or psychoactive substance dependence (Other psychiatric comorbidity is not exclusionary)
- Active suicidal ideation
- Unstable major medical condition
- Plans to engage in additional psychotherapy during the first 6 months after enrollment
- Current use of any medication that has not been stabilized for the previous 2 months
Where it is running
- Department of Psychiatry, Robert Wood Johnson Medical School — Piscataway, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.